severe disease in birds called avian influenza and poses a risk for spillover into the human population," the company said in a statement. Moderna's mRNA pipeline tracker currently shows that ...

In 2023, Moderna started a phase 1/2 study of an experimental pandemic influenza vaccines collectively known as mRNA-1018, which are designed to provide protection against H5 and H7 avian ...

With support from BARDA, Moderna has been developing an mRNA-based vaccine for avian flu for the past several years. That vaccine candidate is on the verge of entering pivotal Phase 3 trials.

Moderna explained that it began Phase 1/2 testing of mRNA-1018 in 2023 in healthy adults aged 18 and up, including candidates against the H5 and H7 avian influenza viruses. It noted that based on ...

Avian influenza, or H5N1, is an extremely contagious ... to pull funding for an mRNA bird flu vaccine being developed by Moderna. Chickens can be vaccinated against bird flu, and countries like ...

has reported its first outbreak of lethal avian flu in a commercial poultry flock in a year, as the nation sees an uptick in cases. Reuters Health Information, November 03, 2023 Moderna Reins in ...